Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 11
Double encephalitis with herpes simplex virus type II and cytomegalovirus in an elder Chinese: a case report
Authors Xue C, Chen S, Lin Q, Zhou H, Huang C, Lin J, Xie W, Chen K, Zhou D, Ma W, Ma F, Xu H
Received 14 July 2015
Accepted for publication 11 September 2015
Published 2 November 2015 Volume 2015:11 Pages 2833—2836
DOI https://doi.org/10.2147/NDT.S92366
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Roger Pinder
Chaobiao Xue,1,2 Shaoxian Chen,1 Qi Lin,1 Houshi Zhou,1 Chuming Huang,1 Jiyuan Lin,1 Weihang Xie,1 Kai Chen,1 Dongming Zhou,1 Wan Ma,1 Feiyu Ma,1 Haiyun Xu2
1Outpatient Department, Shantou Central Hospital, Affiliated Shantou Hospital of Sun Yat-sen University, 2Mental Health Center, Shantou University Medical College, Shantou, Guangdong, People’s Republic of China
Abstract: Herpes simplex encephalitis is a rare disease. In adults, most of the reported cytomegalovirus (CMV) infections are seen in immunocompromised patients. We present a case of 67-year-old Chinese male with the coinfection of CMV and herpes simplex virus type II (HSV-II). He had no history of being treated with immunosuppressants, showed symptoms of psychosis and was scored 109 on the Positive and Negative Syndrome Scale. This patient presented with a rare case of coinfection of CMV and herpes simplex virus type II with psychotic symptoms.
Keywords: brain, viral coinfection, psychotic symptoms
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.